Heading into 2024, expectations for biotech venture capital (VC) and private equity (PE) investments were low following two lackluster years, but as we wrap up Q1, those expectations have been turned on their head after a...more
We’ve all seen the headlines; uncertainty seems to be the only thing that is certain in 2023. On the one hand, geopolitical risks and macroeconomic indicators seem to point toward a likely recession, but on the other hand,...more
Some startup investors might think the biggest innovation to come out of Y Combinator in 2013 was DoorDash — particularly those investors who took part in the company’s early funding rounds and walked away with impressive...more
The National Venture Capital Association (NVCA) published on July 28, 2020 an updated suite of model venture capital financing documents that reflect the current events shaping the investment climate, and for the first time,...more